Now open · A Digital Optometry Solutions product

Parents spend thousands slowing their child's myopia. Prove it's working.

MyoTrack measures how fast a child's short-sightedness is progressing, compares it to what you'd expect without treatment, and turns the answer into a report a parent actually understands — from the spectacle prescription you already take.

Start your 14-day free trial — R199/month →

minutes to
capture a visit

biometers
required

page the parent
takes home

MyoTrack · visit capture Visit 3 of 4

Watercolour anatomical illustration of the human eye showing cornea, lens and retina

📏 Refraction 📊 Verdict 📄 Report

Recording visit measurements

75%

⏱ 1:24 of 2 min target

Amara N. · prescription against age Age 11

Tracked by refraction, which is all most practices need. Each visit is compared only with an earlier one measured the same way.

Right eye Left eye Age-expected untreated growth (config 1.1.0)

Latest interval · 0.00 D/yrControlled

Print the parent report →

How it works

From the chair to the parent's inbox, in four steps

No spreadsheet, no flipping back through three years of cards to work out whether anything has changed.

Capture the visitSphere, cylinder and axis for each eye on a tablet, spherical equivalent calculated for you. A built-in timer keeps the practice honest about the two-minute target.
Get the verdictMyoTrack works out the progression rate, compares it to the age-expected rate for an untreated child, and returns controlled, borderline or rapid — before the child leaves the room.
Show the parentA one-page report in plain language with the growth chart, what you're doing, and what they can do at home. Print it or send it on WhatsApp; an email goes out automatically.
Bring them backEvery review that falls due is queued with the WhatsApp message ready to send. Children leave myopia programmes between visits — this is how you stop it.

Every interval

Each verdict is stored with the config version that produced it.

Visit	SE (OD/OS)	AL (OD/OS)	Rate	Verdict
Sept 2611y 0m	−2.62 / −3.17	— / —	0.00 D/yr	Controlled
Sept 2510y 0m	−2.50 / −3.25	— / —	0.50 D/yr	Borderline
Mar 259y 6m	−2.25 / −3.00	— / —	—	Baseline

You don't need a biometer.

Most myopia software assumes you can measure axial length; outside ophthalmology, very few South African practices can. MyoTrack is built the other way round: cycloplegic refraction is a first-class measurement with its own thresholds. Axial length is there if you have it — and if you buy a biometer later, every existing record keeps working.

Built for clinical practice

Everything the programme needs. Nothing it doesn't.

The verdict

A verdict, not a number dump

Controlled, borderline or rapid — with the arithmetic shown underneath, so you can always see exactly how the answer was reached.

Treatment

Combination treatment plans

Record an optical modality, an atropine concentration, or both together with your instructions to the family. Outcomes attach to what the child was really on.

The report

Reports that justify the fee

One page, plain language, your practice branding. The growth chart puts every measured point against the age-expected untreated reference for that child's age.

Communication

Guardian emails, sent for you

A welcome email when a child joins and a progress email after each review — on the same infrastructure as DryCheck.

Recalls

Reviews that actually happen

Overdue and due-soon children are queued with the message drafted. Every send is logged against the child's record.

Analytics

Your own outcome data

Mean progression by prescription, treatment mix, overdue reviews, programme value — numbers about your own patients no practice can currently produce.

Your own numbers

Outcome data about your own patients

Every verdict rolls up into a practice view almost no independent can currently produce: what you are actually dispensing, how the children on each option are tracking, and which reviews have slipped.

Treatment mix, counted including combination plans
Mean progression by prescription band
Overdue reviews, and what the programme is worth

Prescription mix

What the practice is actually dispensing, including combinations.

No myopia control 2
Cooper Vision Varifocal · Medium 1
DIMS spectacle (MiYOSMART) 1
Other myopia-control spectacle 1

Short-sightedness is an eye that has grown a little too long

Drag the slider. The eye stretches, the picture lands blurred on the retina — and the retina itself is stretched thinner with every millimetre.

Eye length23.5mm

Rough prescription0.00D

What the child seesE

Normal length+4 mm

Each millimetre of stretch ≈ 2.0 D stronger glasses (illustration)

What rises with the stretch Healthy length

A normally-sized eye. This is the finish line the programme defends.

In the consulting room

Swivel the tablet and show them

Parents agree to treatment when they understand what's at stake. The chairside explainer runs in four steps — what myopia is, why it matters, how treatment works, and where this child is heading. The family drags the slider themselves and watches the eye stretch, the picture blur and the retina thin.

An interactive eye the family stretches themselves
Why the risks climb — named conditions, in plain words
The child's own measured pace carried forward to seventeen — labelled on screen as a drawing, not a prediction

How we handle the clinical science

MyoTrack won't claim more than it can measure

Versioned, referenced thresholds

Every threshold and age-expected growth figure lives in one versioned configuration, referenced to published literature and clinically signed off on 23 September 2026 by Kevin Meiring, optometrist (HPCSA OP 0053031). Each verdict is stamped with the version that produced it.

No manufacturer percentages

MyoTrack reports the slowing it has actually measured in that child. A change smaller than the repeatability of the measurement is reported as no change — never as a success.

Decision support, on the record

MyoTrack does not diagnose and does not prescribe — every clinical decision is recorded against the practitioner who made it.

POPIA from the first screen

Guardian consent is captured, with a name and a date, before anything clinical can be stored.

Pricing

One plan. No surprises.

Live · 14-day free trial

R199 per practice / month

14 days free, then billed monthly, in Rand. Unlimited children on the programme. Cancel any time.

Unlimited children on the programme
Progression verdicts from refraction — axial length optional
Parent reports and automatic guardian emails
Chairside explainer and practice dashboard
Review recall queue with drafted WhatsApp messages
The Prescription Visualizer — free with any subscription
Unlimited staff accounts, direct line to the founder

Start your free trial →

Already running DryCheck? MyoTrack is its sibling — same dashboards, same practice palettes, same email setup. Your team already knows how to use it.

FAQ

Common questions

Do I need a biometer to use MyoTrack?

No. MyoTrack is built around cycloplegic refraction, which is how the large majority of South African practices monitor myopia. Refraction has its own progression thresholds and its own age-expected comparison. If you do have a biometer, axial length is recorded alongside and takes precedence — and if you buy one later, every existing record keeps working.

Can I record combination treatment?

Yes. A plan is an optical modality, an atropine concentration, or both together, with the instructions you gave the family. Adding atropine to a spectacle lens is recorded as one plan, and outcomes are attributed to what the child was actually on at the time.

How long does a visit take to capture?

The target is under two minutes on a tablet, and MyoTrack times itself so you can see whether the practice is hitting it. Sphere, cylinder and axis per eye, with the spherical equivalent calculated automatically.

What does the parent actually receive?

A one-page report in plain language — the growth chart, whether the treatment is working, what you're doing, and what to do at home — plus a welcome email when their child joins and a progress email after each review.